What could a new disease activity score for polymyalgia rheumatica do better?

被引：0
|
作者：
Burkhard F. Leeb
机构：
[1] University Clinic for Internal Medicine - Rheumatology,
[2] Karl Landsteiner Institute for Clinical Rheumatology,undefined
来源：
Nature Reviews Rheumatology | 2021年 / 17卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 185
相关论文
共 50 条
  • [21] Plasma Fibrinogen Better Identifies Persistent Disease Activity in Polymyalgia Rheumatica Than Either ESR or CRP
    McCarthy, E. M.
    MacMullan, Paul A.
    Al-Mudhaffer, S.
    Madigan, Anne M.
    Donnelly, S.
    McCarthy, C. J.
    Kenny, Dermot
    Molloy, Eamonn S.
    McCarthy, G. M.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S990 - S990
  • [22] What criteria do general practitioners use to make a diagnosis of polymyalgia rheumatica?
    Barraclough, K
    Liddell, W
    Christopher, F
    du Toit, J
    Thomas, M
    RHEUMATOLOGY, 2005, 44 : I112 - I112
  • [23] Contribution of the Polymyalgia Rheumatica Activity Score to Glucocorticoid Dosage Adjustment in Everyday Practice
    Cleuziou, Caroline
    Binard, Aymeric
    De Bandt, Michel
    Berthelot, Jean-Marie
    Saraux, Alain
    JOURNAL OF RHEUMATOLOGY, 2012, 39 (02) : 310 - 313
  • [24] Classification Criteria and Methods for Assessment of Disease Activity in Polymyalgia Rheumatica
    Dejaco, C.
    Schirmer, M.
    Duftner, C.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 241 - 244
  • [25] Mean platelet volume as a biomarker of disease activity in polymyalgia rheumatica
    Pamuk, G. E.
    Maden, M.
    Pamuk, O. N.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 : 131 - 131
  • [26] Polymyalgia rheumatica: The mess we are now in and what we need to do about it
    Dasgupta, Bhaskar
    Hutchings, Andrew
    Matteson, Eric L.
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2006, 55 (04): : 518 - 520
  • [27] What the IQWiG should (could) do better
    Scriba, P. C.
    Middeke, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (04) : 137 - 138
  • [28] PLASMA FIBRINOGEN IS AN ACCURATE MARKER OF DISEASE ACTIVITY IN PATIENTS WITH POLYMYALGIA RHEUMATICA
    McCarthy, E. M.
    MacMullan, P. A.
    Al-Mudhaffer, S.
    Madigan, A.
    Donnelly, S.
    McCarthy, C.
    Molloy, E.
    McCarthy, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 389 - 390
  • [29] Fibrinogen is a useful marker of disease activity in polymyalgia rheumatica and temporal arteritis
    Quillinan, N. P.
    Kavanagh, P. J.
    O'Shea, F. D.
    McCarthy, C. J.
    McCarthy, G. M.
    RHEUMATOLOGY, 2006, 45 : I170 - I171
  • [30] Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica
    McCarthy, Eoghan M.
    MacMullan, Paul A.
    Al-Mudhaffer, Shibeb
    Madigan, Anne
    Donnelly, Suzanne
    McCarthy, Conor J.
    Molloy, Eamon S.
    Kenny, Dermot
    McCarthy, Geraldine M.
    RHEUMATOLOGY, 2013, 52 (03) : 465 - 471
12345